{"product_id":"fosun-bcg-matrix","title":"Fosun International Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCurious about Fosun International's strategic positioning? Our preview of their BCG Matrix offers a glimpse into how their diverse portfolio might be categorized. You'll see the potential for growth and stability, but to truly unlock the strategic advantage, you need the full picture.\u003c\/p\u003e\n\u003cp\u003eDon't settle for partial insights. Purchase the complete Fosun International BCG Matrix to gain a definitive understanding of their Stars, Cash Cows, Dogs, and Question Marks. This detailed breakdown will empower you to make informed decisions about resource allocation and future investments.\u003c\/p\u003e\n\u003cp\u003eImagine having a clear roadmap to Fosun International's market dominance and potential challenges. The full BCG Matrix provides exactly that, with actionable insights and data-backed recommendations that can transform your own strategic planning.\u003c\/p\u003e\n\u003cp\u003eReady to move beyond speculation? Invest in the complete Fosun International BCG Matrix today and equip yourself with the knowledge to navigate their business landscape with confidence and foresight.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClub Med's Global Premium Resorts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eClub Med, under Fosun International, is a strong contender in the premium resort market. In 2024, its business volume hit €2,090 million, a 7% increase at comparable exchange rates, highlighting its success. This growth is particularly impressive as Club Med has fully transitioned to premium and Exclusive Collection resorts, catering to a discerning clientele.\u003c\/p\u003e\n\u003cp\u003eThe premium positioning is clearly paying off, with mountain resorts showing exceptional growth. These specific locations saw a 20% surge in business volume in 2024, indicating a robust demand for high-end, all-inclusive mountain experiences. This segment is a key driver of Club Med's global performance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun Pharma's Oncology \u0026amp; Immune-Inflammatory Innovative Drugs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFosun Pharma's focus on oncology and immune-inflammatory innovative drugs is a significant driver of its growth. In 2024, the company reported a 16.08% year-on-year increase in net profit, reaching RMB2.77 billion, largely due to its success in this segment. \u003c\/p\u003e\n\u003cp\u003eKey products such as Han Si Zhuang have seen widespread adoption, with approvals in more than 30 countries. Furthermore, their CAR-T cell therapy, Yi Kai Da, has made a substantial impact, benefiting over 800 lymphoma patients in mainland China.\u003c\/p\u003e\n\u003cp\u003eThese advancements, supported by substantial R\u0026amp;D investment and a robust global commercialization strategy, position Fosun Pharma's innovative therapies as strong contenders in rapidly expanding market sectors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun Insurance Portugal\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFosun Insurance Portugal, as a key component of Fosun International’s wealth ecosystem, exhibited robust performance in 2024. The company achieved total gross written premiums of approximately EUR6,172 million, a testament to its sustained growth and operational excellence.\u003c\/p\u003e\n\u003cp\u003eIts overseas revenue surged to EUR1.84 billion in 2024, underscoring its successful international expansion strategy and strong global presence. This significant international revenue highlights Fosun Insurance Portugal's ability to compete effectively in diverse markets.\u003c\/p\u003e\n\u003cp\u003eThis segment consistently generates substantial cash flow, a critical indicator of its financial health and a supporting factor for its star status. The strong cash generation capability allows for reinvestment and further strategic development.\u003c\/p\u003e\n\u003cp\u003eFosun Insurance Portugal commands a high market share in its core and expanding international markets, reinforcing its position as a star performer within the Fosun portfolio. This market dominance signifies its competitive advantage and the trust placed in its offerings by a broad customer base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAtlantis Sanya\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAtlantis Sanya is a shining Star in Fosun International's portfolio, demonstrating exceptional performance as a premier marine-themed resort. In the first half of 2024, it generated an impressive RMB866 million in business volume, underscoring its market leadership. \u003c\/p\u003e\n\u003cp\u003eThe resort’s ability to attract and retain visitors is evident in its record-high average occupancy rate of 89.6%. This consistent strong performance, coupled with a significant market share within the expanding Chinese tourism sector, firmly establishes Atlantis Sanya’s status as a high-growth, high-share asset within Fosun’s happiness segment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eAtlantis Sanya's 2024 Performance:\u003c\/strong\u003e RMB866 million in business volume (H1 2024).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOccupancy Rate:\u003c\/strong\u003e Maintained a record-high average of 89.6%.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Position:\u003c\/strong\u003e Leading one-stop marine-themed integrated resort in China.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBCG Classification:\u003c\/strong\u003e Stars within Fosun's happiness segment due to strong growth and market share.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHenlius's Overseas Commercialization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHenlius, a biopharmaceutical company where Fosun Pharma has a significant stake, is making impressive strides in international markets.  Their innovative products are gaining serious traction, showing strong potential for future growth.  This overseas commercialization is a key indicator for its position within Fosun International's broader business portfolio.\u003c\/p\u003e\n\u003cp\u003eKey milestones include the marketing approval of HANSIZHUANG in the European Union and the U.S. and Canadian approvals for HANQUYOU in early 2025. These approvals in major regulatory regions highlight the global demand for Henlius's advanced biopharmaceutical offerings.\u003c\/p\u003e\n\u003cp\u003eThis expansion signifies a substantial increase in market share for these cutting-edge products, reflecting Henlius's growing capabilities and market penetration. The successful entry into these key markets is a testament to the company's research and development prowess.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Market Entry:\u003c\/strong\u003e HANSIZHUANG approved in the EU, HANQUYOU approved in the US and Canada (early 2025).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Growth Potential:\u003c\/strong\u003e Demonstrates significant international demand and market acceptance for innovative biopharmaceuticals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIncreasing Market Share:\u003c\/strong\u003e Successful global expansion leads to a growing presence in key regulated markets.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun Pharma's Stellar Growth: Oncology \u0026amp; Immunology Lead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFosun Pharma's innovative drugs, particularly in oncology and immunology, are classified as Stars. In 2024, Fosun Pharma's net profit increased by 16.08% to RMB2.77 billion, driven by these successful segments. Products like Han Si Zhuang are approved in over 30 countries, and Yi Kai Da CAR-T therapy has benefited over 800 patients in China, demonstrating high growth and market share.\u003c\/p\u003e\n\u003cp\u003eHenlius, a Fosun Pharma affiliate, also shows Star potential with significant international expansion. HANSIZHUANG gained EU marketing approval, and HANQUYOU received US and Canadian approval in early 2025. This global market penetration indicates strong growth and increasing market share for their biopharmaceutical innovations.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThis BCG Matrix overview analyzes Fosun International's portfolio, identifying Stars for growth, Cash Cows for funding, Question Marks for potential, and Dogs for divestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe Fosun International BCG Matrix offers a clear, one-page overview, instantly relieving the pain of scattered business unit performance data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun Pharma's Established Generic Drug Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFosun Pharma's established generic drug portfolio represents a significant cash cow for Fosun International. These products, like their established cardiovascular and antibiotic medications, operate in mature markets where demand is stable, and Fosun Pharma often holds a considerable market share. This consistency in sales and demand allows these generics to generate predictable and substantial cash flow.\u003c\/p\u003e\n\u003cp\u003eThe operational efficiency and extensive distribution networks for these established generics mean they contribute significantly to Fosun Pharma's profitability without demanding large, ongoing investments in research and development or marketing. For instance, in 2023, Fosun Pharma's generics segment continued to be a reliable revenue generator, underpinning the company's financial stability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYuyuan's Core Consumer Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eYuyuan, a key pillar within Fosun International's structure, significantly contributes to the company's happiness segment, with a strong focus on household consumption.  While brand-specific financial details aren't publicly segmented, its role as a core subsidiary implies a robust market presence.\u003c\/p\u003e\n\u003cp\u003eAs part of Fosun's core subsidiaries, which collectively generated 70.1% of the group's total revenue in 2023, Yuyuan benefits from established consumer goods categories within China. This strong market share translates into dependable revenue streams.\u003c\/p\u003e\n\u003cp\u003eThese mature brands within Yuyuan likely operate as cash cows, meaning they generate substantial and consistent profits with minimal need for significant reinvestment to maintain their market position. This stability is vital for Fosun's overall financial health.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun's Traditional Insurance Business (excluding growth areas)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFosun's traditional insurance business, a cornerstone of its wealth segment, continues to be a reliable generator of income. While not experiencing the rapid expansion of its international ventures, these mature operations boast a loyal customer base and a solid market position, ensuring consistent premium collections and profits. This stability provides a crucial financial bedrock, enabling Fosun to allocate capital towards its growth-oriented initiatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eForyou Club Membership Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Foryou Club Membership Platform, a key component of Fosun International's tourism business, functions as a cash cow within the BCG matrix.  In the first half of 2024, it achieved a business volume of RMB173 million and boasted over 6.9 million members. This indicates a stable, established customer base that consistently contributes to revenue. \u003c\/p\u003e\n\u003cp\u003eWhile not experiencing explosive growth, the platform's strength lies in its loyalty and recurring revenue streams from membership operations and digital services. It represents a mature offering that reliably supports the tourism segment's financial performance. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eForyou Club's business volume:\u003c\/strong\u003e RMB173 million (H1 2024)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForyou Club's membership base:\u003c\/strong\u003e Over 6.9 million members (H1 2024)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePlatform role:\u003c\/strong\u003e Stable revenue generation through loyalty and digital services\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket position:\u003c\/strong\u003e Mature offering contributing steadily to Fosun Tourism\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVacation Asset Management Center\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Vacation Asset Management Center, a component of Fosun International's tourism segment, specializes in overseeing vacation properties, including those belonging to external parties. This business unit generated RMB294.01 million in revenue during the first half of 2024.\u003c\/p\u003e\n\u003cp\u003eThis operation is characterized by its focus on managing existing vacation assets, which typically translates to a more moderate growth trajectory. However, its core function of optimizing asset utilization and earning management fees positions it as a reliable source of stable income.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocus:\u003c\/strong\u003e Management of vacation assets, including third-party destinations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eH1 2024 Revenue:\u003c\/strong\u003e RMB294.01 million.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBCG Matrix Classification:\u003c\/strong\u003e Likely a Cash Cow due to stable income from management fees and asset optimization, with potentially lower growth compared to other units.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Implication:\u003c\/strong\u003e Provides consistent cash flow to support other business units or investments within Fosun.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFosun's Cash Cows: Steady Revenue Streams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFosun International's established generic drug portfolio, particularly within Fosun Pharma, continues to function as a reliable cash cow. These products operate in mature markets with stable demand, ensuring predictable revenue generation. For example, in 2023, the generics segment remained a stable contributor to Fosun Pharma's financial performance.\u003c\/p\u003e\n\u003cp\u003eYuyuan, a core subsidiary, leverages its strong market presence in established consumer goods categories within China, contributing significantly to Fosun's overall revenue. Its role as a stable revenue generator, likely with minimal reinvestment needs, solidifies its cash cow status.\u003c\/p\u003e\n\u003cp\u003eThe Foryou Club Membership Platform and Vacation Asset Management Center within Fosun Tourism also exhibit cash cow characteristics. The Foryou Club reported RMB173 million in business volume and over 6.9 million members in the first half of 2024, indicating consistent revenue from loyalty and digital services.\u003c\/p\u003e\n\u003cp\u003eThe Vacation Asset Management Center generated RMB294.01 million in revenue during the first half of 2024, focusing on optimizing existing assets and earning management fees, which points to stable income generation.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eBusiness Unit\u003c\/th\u003e\n\u003cth\u003eBCG Category\u003c\/th\u003e\n\u003cth\u003eKey Financial Data (2023\/H1 2024)\u003c\/th\u003e\n\u003cth\u003eStrategic Role\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFosun Pharma Generics\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eStable revenue generator (2023 data)\u003c\/td\u003e\n\u003ctd\u003eUnderpins financial stability, predictable cash flow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYuyuan\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eContributes to 70.1% of group revenue (2023) via established consumer goods\u003c\/td\u003e\n\u003ctd\u003eDependable revenue streams, stable profits\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForyou Club Membership\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eRMB173 million business volume, 6.9M+ members (H1 2024)\u003c\/td\u003e\n\u003ctd\u003eRecurring revenue from loyalty and digital services\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVacation Asset Management\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eRMB294.01 million revenue (H1 2024)\u003c\/td\u003e\n\u003ctd\u003eStable income from asset optimization and management fees\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eFosun International BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe Fosun International BCG Matrix preview you are viewing is the complete and final document you will receive upon purchase. This means you are seeing the exact strategic analysis, including all data points and visual representations, that will be delivered to you, ready for immediate application in your business planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55480836522361,"sku":"fosun-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/fosun-bcg-matrix.png?v=1752757923","url":"https:\/\/growthsharematrix.com\/products\/fosun-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}